Wednesday, March 23, 2016
ImpediMed Raises $56.8M In Private Placement
ImpediMed, a developer of medical devices used to measure, monitor, and manage fluid status in patients, said Tuesday that it has raised $56.8M in a private placement. The company--which is based in Australia, but has its U.S. headquarters in Carlsbad--said it raised A$75.1M in its private placement with institutional investors. The funding was managed by Canaccord Genuity (Australia) Limited. The company's medical technology is used in treatment of chronic heart failure.